Article: Physical Activity Limitations In Children With Severe Haemophilia A. Does Emicizumab Make A Difference?
JPMA. The Journal of the Pakistan Medical Association
2023 Volume 73Suppl 4, Issue 4, Page(s) S31–S33
Abstract: Objectives: To assess the effect of emicizumab on physical activity in children with severe haemophilia A.: Methods: The prospective cohortstudy was conducted from October 2021 to April 2022 at the Paediatric Department of Kafrelsheikh University ... ...
Abstract | Objectives: To assess the effect of emicizumab on physical activity in children with severe haemophilia A. Methods: The prospective cohortstudy was conducted from October 2021 to April 2022 at the Paediatric Department of Kafrelsheikh University Hospital, Egypt, in collaboration with the Haematology out-patient clinic of the Paediatric Department, Zagazig University, Egypt, and the Paediatric Department of Cairo University Hospital, Egypt, and comprised children aged 4-18 years with severe haemophilia A who received emicizumab prophylaxis. Paediatric Haemophilia Activities List was used to assess physical activity at baseline and aftersix months of regular emicizumab prophylaxis. Data was analysed using SPSS 26. Results: There were 29 children, all (100%) boys, with mean age 8.7±3.51 years(range 4-15 years. Of them, 17(58.62%) patients were negative for inhibitors. Median Paediatric Haemophilia Activities Listsum score was 59.54 (interquartile range: 50.15-62.05) at baseline which moved up to 84 (interquartile range: 79.05-86.35) post-intervention (p<0.001). Conclusions: Emicizumab prophylaxis improved the level of physical activity in children with severe haemophilia A. |
---|---|
MeSH term(s) | Male ; Humans ; Child ; Child, Preschool ; Adolescent ; Female ; Hemophilia A/drug therapy ; Prospective Studies ; Antibodies, Bispecific/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use |
Chemical Substances | emicizumab (7NL2E3F6K3) ; Antibodies, Bispecific ; Antibodies, Monoclonal, Humanized |
Language | English |
Publishing date | 2023-07-23 |
Publishing country | Pakistan |
Document type | Journal Article |
ZDB-ID | 603873-6 |
ISSN | 0030-9982 |
ISSN | 0030-9982 |
DOI | 10.47391/JPMA.EGY-S4-10 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 845: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.